111 related articles for article (PubMed ID: 37728485)
21. CDK4/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner.
Zhang QF; Li J; Jiang K; Wang R; Ge JL; Yang H; Liu SJ; Jia LT; Wang L; Chen BL
Theranostics; 2020; 10(23):10619-10633. PubMed ID: 32929370
[TBL] [Abstract][Full Text] [Related]
22. Identification of a lipolysis-stimulated receptor that is distinct from the LDL receptor and the LDL receptor-related protein.
Yen FT; Mann CJ; Guermani LM; Hannouche NF; Hubert N; Hornick CA; Bordeau VN; Agnani G; Bihain BE
Biochemistry; 1994 Feb; 33(5):1172-80. PubMed ID: 7509190
[TBL] [Abstract][Full Text] [Related]
23. The Behavior and Role of Lipolysis-stimulated Lipoprotein Receptor, a Component of Tricellular Tight Junctions, in Head and Neck Squamous Cell Carcinomas.
Takano K; Kakuki T; Obata K; Nomura K; Miyata R; Kondo A; Kurose M; Kakiuchi A; Kaneko Y; Kohno T; Himi T; Kojima T
Anticancer Res; 2016 Nov; 36(11):5895-5904. PubMed ID: 27793914
[TBL] [Abstract][Full Text] [Related]
24. Interaction of
Nagahama M; Takehara M; Kobayashi K
Toxins (Basel); 2018 Oct; 10(10):. PubMed ID: 30297616
[TBL] [Abstract][Full Text] [Related]
25. ASPP2 suppression promotes malignancy via LSR and YAP in human endometrial cancer.
Konno T; Kohno T; Okada T; Shimada H; Satohisa S; Kikuchi S; Saito T; Kojima T
Histochem Cell Biol; 2020 Aug; 154(2):197-213. PubMed ID: 32266459
[TBL] [Abstract][Full Text] [Related]
26. Loss of tricellular tight junction protein LSR promotes cell invasion and migration via upregulation of TEAD1/AREG in human endometrial cancer.
Shimada H; Abe S; Kohno T; Satohisa S; Konno T; Takahashi S; Hatakeyama T; Arimoto C; Kakuki T; Kaneko Y; Takano KI; Saito T; Kojima T
Sci Rep; 2017 Jan; 7():37049. PubMed ID: 28071680
[TBL] [Abstract][Full Text] [Related]
27. Interaction of the Clostridium difficile Binary Toxin CDT and Its Host Cell Receptor, Lipolysis-stimulated Lipoprotein Receptor (LSR).
Hemmasi S; Czulkies BA; Schorch B; Veit A; Aktories K; Papatheodorou P
J Biol Chem; 2015 May; 290(22):14031-44. PubMed ID: 25882847
[TBL] [Abstract][Full Text] [Related]
28. HMGB1-downregulated angulin-1/LSR induces epithelial barrier disruption via claudin-2 and cellular metabolism via AMPK in airway epithelial Calu-3 cells.
Kodera Y; Chiba H; Konno T; Kohno T; Takahashi H; Kojima T
Biochem Biophys Res Commun; 2020 Jun; 527(2):553-560. PubMed ID: 32423802
[TBL] [Abstract][Full Text] [Related]
29. Clostridium difficile binary toxin CDT induces clustering of the lipolysis-stimulated lipoprotein receptor into lipid rafts.
Papatheodorou P; Hornuss D; Nölke T; Hemmasi S; Castonguay J; Picchianti M; Aktories K
mBio; 2013 Apr; 4(3):e00244-13. PubMed ID: 23631918
[TBL] [Abstract][Full Text] [Related]
30. Pyk2-dependent phosphorylation of LSR enhances localization of LSR and tricellulin at tricellular tight junctions.
Nakatsu D; Kano F; Shinozaki-Narikawa N; Murata M
PLoS One; 2019; 14(10):e0223300. PubMed ID: 31574128
[TBL] [Abstract][Full Text] [Related]
31. Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8
Semmrich M; Marchand JB; Fend L; Rehn M; Remy C; Holmkvist P; Silvestre N; Svensson C; Kleinpeter P; Deforges J; Junghus F; Cleary KL; Bodén M; Mårtensson L; Foloppe J; Teige I; Quéméneur E; Frendéus B
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35058324
[TBL] [Abstract][Full Text] [Related]
32. Modulation of the tumor microenvironment by intratumoral administration of IMO-2125, a novel TLR9 agonist, for cancer immunotherapy.
Wang D; Jiang W; Zhu F; Mao X; Agrawal S
Int J Oncol; 2018 Sep; 53(3):1193-1203. PubMed ID: 29956749
[TBL] [Abstract][Full Text] [Related]
33. Focal radiation therapy combined with 4-1BB activation and CTLA-4 blockade yields long-term survival and a protective antigen-specific memory response in a murine glioma model.
Belcaid Z; Phallen JA; Zeng J; See AP; Mathios D; Gottschalk C; Nicholas S; Kellett M; Ruzevick J; Jackson C; Albesiano E; Durham NM; Ye X; Tran PT; Tyler B; Wong JW; Brem H; Pardoll DM; Drake CG; Lim M
PLoS One; 2014; 9(7):e101764. PubMed ID: 25013914
[TBL] [Abstract][Full Text] [Related]
34. CD4
Kristensen LK; Fröhlich C; Christensen C; Melander MC; Poulsen TT; Galler GR; Lantto J; Horak ID; Kragh M; Nielsen CH; Kjaer A
Theranostics; 2019; 9(26):8221-8238. PubMed ID: 31754392
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of activation and functional significance of the lipolysis-stimulated receptor. Evidence for a role as chylomicron remnant receptor.
Mann CJ; Khallou J; Chevreuil O; Troussard AA; Guermani LM; Launay K; Delplanque B; Yen FT; Bihain BE
Biochemistry; 1995 Aug; 34(33):10421-31. PubMed ID: 7654696
[TBL] [Abstract][Full Text] [Related]
36. Molecular cloning of a lipolysis-stimulated remnant receptor expressed in the liver.
Yen FT; Masson M; Clossais-Besnard N; André P; Grosset JM; Bougueleret L; Dumas JB; Guerassimenko O; Bihain BE
J Biol Chem; 1999 May; 274(19):13390-8. PubMed ID: 10224102
[TBL] [Abstract][Full Text] [Related]
37. Lipolysis-Stimulated Lipoprotein Receptor Impairs Hepatocellular Carcinoma and Inhibits the Oncogenic Activity of YAP1
Dong X; Zhang X; Liu P; Tian Y; Li L; Gong P
Front Oncol; 2022; 12():896412. PubMed ID: 35586495
[TBL] [Abstract][Full Text] [Related]
38. Sensitizing tumors to anti-PD-1 therapy by promoting NK and CD8+ T cells via pharmacological activation of FOXO3.
Chung YM; Khan PP; Wang H; Tsai WB; Qiao Y; Yu B; Larrick JW; Hu MC
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34887262
[TBL] [Abstract][Full Text] [Related]
39. LSR antibody promotes apoptosis and disrupts epithelial barriers via signal pathways in endometrial cancer.
Saito K; Konno T; Kohno T; Shimada H; Matsuura M; Okada T; Kura A; Ishii D; Kondoh M; Saito T; Kojima T
Tissue Barriers; 2023 Jul; 11(3):2106113. PubMed ID: 35883247
[TBL] [Abstract][Full Text] [Related]
40. B Cells Are Required to Generate Optimal Anti-Melanoma Immunity in Response to Checkpoint Blockade.
Singh S; Roszik J; Saini N; Singh VK; Bavisi K; Wang Z; Vien LT; Yang Z; Kundu S; Davis RE; Bover L; Diab A; Neelapu SS; Overwijk WW; Rai K; Singh M
Front Immunol; 2022; 13():794684. PubMed ID: 35720386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
